Vijaya Diagnostic Centre Ltd (VIJAYA) — Announcement | 11 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Vijaya acquires Arya Wellness Centre in Guwahati for ₹46 crore via slump sale.
🔄 What Changed
Entry into North-East market; first B2C diagnostic acquisition in Assam
🔮 What's Next
Transaction expected to close within ~three months
💡 Investor Takeaway
This acquisition expands Vijaya's diagnostic network into Assam, creating growth opportunities in Eastern India.

Vijaya Diagnostic Centre announced its acquisition of Arya Wellness Centre in Guwahati for approximately ₹46 crore via a slump sale, marking its entry into North-East India diagnostics. The deal, valued at 8-9x FY26 EBITDA, is expected to close in three months and will be EPS accretive from day one, strengthening its B2C integrated diagnostic network in Eastern India.

📄 View Original Announcement (PDF)

About Vijaya Diagnostic Centre Ltd (VIJAYA)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹15,458.18 Cr P/E: 82.4 ROE: 23.6% ROCE: 36.2% Div Yield: 0.13%

View full VIJAYA stock details →

📡 Get AI alerts when VIJAYA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIJAYA — Free

📊 More VIJAYA filings

See all VIJAYA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIJAYA files new disclosures

Track VIJAYA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIJAYA — Free

Free account · 2 AI queries/day